[Use of nevigramon in acute and chronic pyelonephritis before and after kidney transplantation].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001437:Bacteriuria; D002908:Chronic Disease; D003864:Depression, Chemical; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D009268:Nalidixic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D010406:Penicillins / Q000627:therapeutic use; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D013210:Staphylococcus / Q000187:drug effects; D014184:Transplantation, Homologous; D014839:Vomiting / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D010406:Penicillins; D009268:Nalidixic Acid
Opyt primeneniia nevigramona pri ostrom i khronicheskom pielonefrite do i posle transplantatsii pochki.